Literature DB >> 22682300

Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.

Jes Gitz Holler1, Hans-Christian Slotved, Per Mølgaard, Carl Erik Olsen, Søren Brøgger Christensen.   

Abstract

A library of 117 chalcones was screened for efflux pump inhibitory (EPI) activity against NorA mediated ethidium bromide efflux. Five of the chalcones (5-7, 9, and 10) were active and two chalcones (9 and 10) were equipotent to reserpine with IC(50)-values of 9.0 and 7.7 μM, respectively. Twenty chalcones were subsequently proved to be inhibitors of the NorA efflux pump in everted membrane vesicles. Compounds 5, 7, and 9 synergistically increased the effect of ciprofloxacin on Staphylococcus aureus. Our results suggest that chalcones might be developed into drugs for overcoming multidrug resistance based on efflux transporters of microorganisms.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22682300     DOI: 10.1016/j.bmc.2012.05.025

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  14 in total

Review 1.  Tackling Multiple-Drug-Resistant Bacteria With Conventional and Complex Phytochemicals.

Authors:  Thangaiyan Suganya; Issac Abraham Sybiya Vasantha Packiavathy; G Smilin Bell Aseervatham; Areanna Carmona; Vijayaragavan Rashmi; Subramanian Mariappan; Navaneethan Renuga Devi; Devanesan Arul Ananth
Journal:  Front Cell Infect Microbiol       Date:  2022-06-30       Impact factor: 6.073

Review 2.  Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens.

Authors:  Jody L Andersen; Gui-Xin He; Prathusha Kakarla; Ranjana K C; Sanath Kumar; Wazir Singh Lakra; Mun Mun Mukherjee; Indrika Ranaweera; Ugina Shrestha; Thuy Tran; Manuel F Varela
Journal:  Int J Environ Res Public Health       Date:  2015-01-28       Impact factor: 3.390

3.  Modulation of Bacterial Multidrug Resistance Efflux Pumps of the Major Facilitator Superfamily.

Authors:  Sanath Kumar; Mun Mun Mukherjee; Manuel F Varela
Journal:  Int J Bacteriol       Date:  2013

Review 4.  Challenges and future prospects of antibiotic therapy: from peptides to phages utilization.

Authors:  Santi M Mandal; Anupam Roy; Ananta K Ghosh; Tapas K Hazra; Amit Basak; Octavio L Franco
Journal:  Front Pharmacol       Date:  2014-05-13       Impact factor: 5.810

Review 5.  Efflux pump inhibitors for bacterial pathogens: From bench to bedside.

Authors:  Atin Sharma; Vivek Kumar Gupta; Ranjana Pathania
Journal:  Indian J Med Res       Date:  2019-02       Impact factor: 2.375

Review 6.  Review on plant antimicrobials: a mechanistic viewpoint.

Authors:  Bahman Khameneh; Milad Iranshahy; Vahid Soheili; Bibi Sedigheh Fazly Bazzaz
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-16       Impact factor: 4.887

7.  Deciphering the Molecular Recognition Mechanism of Multidrug Resistance Staphylococcus aureus NorA Efflux Pump Using a Supervised Molecular Dynamics Approach.

Authors:  Deborah Palazzotti; Maicol Bissaro; Giovanni Bolcato; Andrea Astolfi; Tommaso Felicetti; Stefano Sabatini; Mattia Sturlese; Violetta Cecchetti; Maria Letizia Barreca; Stefano Moro
Journal:  Int J Mol Sci       Date:  2019-08-19       Impact factor: 5.923

Review 8.  Functional and Structural Roles of the Major Facilitator Superfamily Bacterial Multidrug Efflux Pumps.

Authors:  Sanath Kumar; Manjusha Lekshmi; Ammini Parvathi; Manisha Ojha; Nicholas Wenzel; Manuel F Varela
Journal:  Microorganisms       Date:  2020-02-16

9.  The intrinsic resistome of bacterial pathogens.

Authors:  Jorge Olivares; Alejandra Bernardini; Guillermo Garcia-Leon; Fernando Corona; Maria B Sanchez; Jose L Martinez
Journal:  Front Microbiol       Date:  2013-04-30       Impact factor: 5.640

Review 10.  Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus.

Authors:  Jadwiga Handzlik; Anna Matys; Katarzyna Kieć-Kononowicz
Journal:  Antibiotics (Basel)       Date:  2013-02-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.